ArticleBMJ (Clinical research ed.)2020
Making pharmaceutical research and regulation work for women.
Article in BMJ (Clinical research ed.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Engagement in women's health: a history.Research involvement and engagement · 2026Article
- Article
- Intersectoral action to transform health equity for women and girls globally.Communications medicine · 2025Review
- Breaking the Cycle: Why Women of Reproductive Age Belong in All Areas of Health Research.BJOG : an international journal of obstetrics and gynaecology · 2025Article
- Article
- Points to Consider on the Use of Medicines in Pregnancy Throughout the Product Lifecycle Based on Global Regulatory Guidance.Therapeutic innovation & regulatory science · 2025Review
- Are sex and gender dimensions accounted for in NICE guidelines? A systematic review of 223 clinical guidelines.BMJ public health · 2025Article
- Emerging Ethical Challenges in Manufacturing of Cell-Based Medicines.Advances in experimental medicine and biology · 2025Review
- Treating Mycoplasma genitalium (in pregnancy): a social and reproductive justice concern.Monash bioethics review · 2024Article
- Promoting equity in clinical research: The role of social determinants of health.Journal of biomedical informatics · 2024Article
- Paving the way towards medicines for women and men.European journal of clinical pharmacology · 2024Article
- Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials.Pharmaceutical medicine · 2024Review
- Sex as a Biological Variable in Early-Phase Oncology Clinical Trials: Enhancing the Path to Personalised Medicine.Heliyon · 2024Review
- Exclusion of pregnant and lactating persons from breast cancer clinical trials: a review of active trials registered on ClinicalTrials.gov.Acta obstetricia et gynecologica Scandinavica · 2024Review
- Vascular Diseases in Women: Do Women Suffer from Them Differently?Journal of clinical medicine · 2024Review
- The Appropriateness of Medical Devices Is Strongly Influenced by Sex and Gender.Life (Basel, Switzerland) · 2024Review
- Catalysing change in health and medical research policy: an Australian case study of deliberative democracy to reform sex and gender policy recommendations.Frontiers in public health · 2024Article
- Sex bias in prospective follow-up observational studies with drugs carried out in a southern region of Europe.Frontiers in pharmacology · 2024Article
- Multimorbidity of cardiovascular disease subtypes in a prospective cohort of 1.2 million UK women.Open heart · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.